Topic: How To Invest

Pat, Can you please give me your opinion on Titan Medical Inc.? Regards.

Article Excerpt

Titan Medical, $0.40, symbol TMD on Toronto (Shares outstanding: 19.4 million; Market cap: $7.8 million), is developing Amadeus, a four-armed robotic surgical system. Amadeus is designed to let surgeons remotely manipulate surgical instruments. Titan’s products are still under development, so it has yet to generate any revenue. In the nine months ended September 30, 2009, the company lost $295,498, or $0.08 a share. It holds cash of $1.4 million, or $0.07 a share. Titan recently signed a contract with flight-simulator maker CAE Inc. Under the terms of the deal, CAE will be the exclusive training provider for Amadeus. In exchange, Titan will gain access to CAE’s modelling and simulation expertise. The contract has attracted a lot of investor interest in Titan. Over the past 10 years, robotic surgery has developed into a proven and growing method of treatment. However, Titan must still spend heavily on research to fully develop its systems. It will then need to conduct an extensive sales and…